Accenture and Lundbeck used a knowledge graph and ML to find headache drug targets 80% faster.
Headache disorders involve thousands of possible genetic links and slow literature and lab methods. They built a knowledge graph combining 54 million electronic medical records with public biological data and trained ML to predict gene-disease associations. The page states targets identified 80% faster and 77% of known associations detected.
Accenture is a global consultancy and systems integrator that builds AI, data and cloud platforms for pharma companies across R&D, supply and commercial
This sits in the Build stage of the AI use-case lifecycle: Named examples from the foundation-model labs and platforms pharma teams use to actually construct, train and generate the model or application.
Published by Accenture on its own site — read the original case study on accenture.com ↗
Related use cases
- 01Accenture and BMS deployed 30+ generative AI solutions, including the Workbench clinical trial platform.
- 02Accenture built Novartis a multi-cloud AI and analytics platform spanning manufacturing and quality data.
- 03Accenture Labs and 1QBit built a quantum-enabled molecular comparison application for Biogen.
- 04OpenAI's dedicated healthcare vertical page/launch post.
- 05Frontier reasoning model built for biology, drug discovery and translational medicine; named qualified customers include Amgen, Moderna, Allen Institute, and Thermo Fisher Scientific.
- 06follow-up update to the life-sciences model.